Filing Details

Accession Number:
0001493152-15-006115
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-12-08 11:30:26
Reporting Period:
2015-11-27
Filing Date:
2015-12-08
Accepted Time:
2015-12-08 11:30:26
Original Submission Date:
2015-11-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1459632 S Mark Leventhal 621 N. Shady Retreat Road
Doylestown PA 18901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0005 Acquisiton 2015-11-27 13,300 $1.55 881,032 No 4 P Direct
Common Stock, Par Value $0.0005 Acquisiton 2015-11-30 948 $1.48 881,980 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 30, 2015.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.56, inclusive.
  3. These shares were purchased in a single transaction at a price of $1.48.